Search results (26)
« Back to NewsThe latest news, stories and exciting findings from across the Oxford cancer research community
Oxford Cancer: 5 minutes with Professor Dame Molly Stevens
23 May 2024
Professor Dame Molly Stevens is John Black Professor of Bionanoscience in the Department of Physiology, Anatomy and Genetics and the Institute of Biomedical Engineering. She recently moved her lab from Imperial College London to the University of Oxford and the Kavli Institute for nanoscience discovery, and she is joining the Oxford Cancer community.
AI reveals prostate cancer is not just one disease
29 February 2024
Artificial Intelligence has helped scientists reveal a new form of aggressive prostate cancer which could revolutionise how the disease is diagnosed and treated in the future.
Prostate cancer AI diagnosis tool begins evaluation in Oxford
10 March 2023
Researchers and clinicians in Oxford have begun an evaluation of artificial intelligence (AI) software that could help pathologists diagnose prostate cancer.
Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology
6 October 2022
Optellum, a University of Oxford spinout that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round.
Automated assessment of pathology image quality
6 April 2022
The new Oxford-developed artificial intelligence tool PathProfiler automates the quality control of large retrospective pathology image datasets to increase their usability in downstream research.
Oxford spin-out Optellum attains CE marking for its early lung cancer diagnosis AI technology
5 April 2022
Optellum Virtual Nodule Clinic, including its proprietary artificial intelligence lung cancer prediction solution, has achieved CE certification under the European Union’s Medical Device Regulation.
How Oxford has shaped cancer science
4 February 2022
As part of World Cancer Day 2022 we are diving into 10 of Oxford’s most impactful historical and modern contributions to the field of cancer science and treatment. Read more about what Oxford researchers have done to shape this ever-important area of medical science.
New healthcare partnership for Oxfordshire cancer research spin-out
29 November 2021
Oxford University spin-out Optellum have announced their collaboration with GE Healthcare to advance lung cancer diagnosis using artificial intelligence.
Datasets used to train AI to detect skin cancer lack information on darker skin and often incomplete
10 November 2021
Research by Oxford University Hospital academics have found the images and data available for training AI to spot skin cancer are insufficient and include very few images of darker skin.
Oxford ranked first in the world for Computer Science
22 October 2021
For the fourth year running the University of Oxford has been ranked first in the world for Computer Science in the 2022 World University Rankings. Many Oxford Cancer members are working in computer science to develop AI algorithms to detect cancer earlier, and implement machine learning into new technologies.
Turing Fellowships for Oxford cancer researchers
1 October 2021
Oxford Cancer community members will join the Turing network for 2021-2022 to further their research in cancer big data.
Oxford Cancer Analytics awarded £1.27M to revolutonise lung cancer management
10 September 2021
OXcan, an Oxford University spin out, has raised money to apply their machine learning approach to lung cancer early detection
Oxford spin out partners with J&J to transform lung cancer treatment
18 August 2021
Optellum, a lung health start-up in Oxford, aims to redefine early interception of lung cancer using artificial intelligence (AI) decision support software.
AI software to help clinicians diagnose lung cancer earlier and reduce patient waiting lists
26 July 2021
A new artificial intelligence software that will help doctors to make quicker and more accurate decisions when diagnosing potentially cancerous lung lesions, has received major government funding.
Oxford wins government funding to evaluate prostate cancer detection system
24 June 2021
A prostate cancer detection software system to help pathologists quickly identify suspicious areas of tissue, developed by Paige, will be investigated in a multicentre clinical study led by Oxford University.
AI endoscopy project enables 3D surface measurements of Barrett's oesophagus
9 June 2021
Clinicians and engineers in Oxford have begun using artificial intelligence alongside endoscopy to get more accurate readings of the pre-cancerous condition Barrett’s oesophagus and so determine patients most at risk of developing cancer.
Artificial intelligence tool for streamlining pathology workflow
26 May 2021
A multidisciplinary team in Oxford has developed an algorithm for automated requesting of additional investigation in diagnostically uncertain prostate biopsies.
Oxford spin out influencing patient care world wide
27 March 2021
Oxford cancer research spin our Optellum has received FDA clearance for the world’s first AI-powered clinical decision support for early lung cancer diagnosis
Developing a system to simultaneously detect genetic and epigenetic information
2 March 2021
Dr Benjamin Schuster-Böckler wins funding to develop algorithms that can identify both genetic variation and DNA methylation from the same sequencing data, with applications in biomedical research and detection of diseases such as cancer.
Using AI to improve the quality of endoscopy videos
25 November 2020
A multidisciplinary team of researchers has developed a deep-learning framework for improving endoscopy to aid cancer detection.